scholarly journals Advanced Practice Internship: Experiential Learning in a Drug Use and Disease State Management Program

2006 ◽  
Vol 70 (3) ◽  
pp. 68 ◽  
Author(s):  
Susan J. Skledar ◽  
Teresa P. McKaveney ◽  
Charles O. Ward ◽  
Colleen M. Culley ◽  
Kelly C. Ervin ◽  
...  
Keyword(s):  
Drug Use ◽  
Experiential Learning ◽  
Management Program ◽  
Disease State ◽  
Advanced Practice ◽  
State Management ◽  
Disease State Management

Preliminary Results From a Multidisciplinary University-Based Disease State Management Program Focused on Hypertension, Hyperlipidemia, and Diabetes

2011 ◽  
Vol 25 (2) ◽  
pp. 130-135 ◽  
Author(s):  
David R. Bright ◽  
Kelly R. Kroustos ◽  
Rhonda E. Thompson ◽  
Scott C. Swanson ◽  
Sara L. Terrell ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Clinical Outcomes ◽  
Exercise Physiology ◽  
Pressure Control ◽  
Management Program ◽  
Disease State ◽  
State Management ◽  
Disease State Management ◽  
Patients With Diabetes ◽  
Fitness Parameters

Objective: To describe the implementation and evaluation of a pilot multidisciplinary disease state management (DSM) program for diabetes, hypertension, and hyperlipidemia at a private, self-insured university (over 900 covered lives). Methods: Enrollees met with a pharmacist, nurse, exercise physiologist, and students in these disciplines to improve clinical outcomes and fitness parameters. Clinical values, quality of life, patient knowledge of disease states, and patient satisfaction were assessed. Results: Of the 20 patients in the pilot program, 17 completed 1 nursing and 2 pharmacist visits; 8 completed exercise physiology visits. At baseline, elevated blood pressure readings were observed in 64.7% (11 of 17) of patients, 20% of those with diabetes (1 of 5) had an elevated hemoglobin A1c value (HbA1c), and 82.4% (14 of 17) had a cholesterol value that was not at goal. At least 1 medication-related problem was observed in 16 patients (94.1%). At 3 months, all patients with diabetes achieved HbA1c levels at or below 7%, 4 patients attained blood pressure control, and 1 achieved normal cholesterol readings. Patients characterized participation in the program as valuable and convenient. Conclusions: Patients involved in the multidisciplinary DSM showed improved clinical outcomes after 3 months. Ongoing analysis of patient outcomes will determine the long-term effectiveness of the DSM.

Evaluation of a disease state management guideline for urinary tract infection

2016 ◽  
Vol 47 (6) ◽  
pp. 451-456 ◽  
Author(s):  
Monika T. Zmarlicka ◽  
Sophia M. Cardwell ◽  
Jared L. Crandon ◽  
David P. Nicolau ◽  
Mitchell H. McClure ◽  
...  
Keyword(s):  
Urinary Tract Infection ◽  
Urinary Tract ◽  
Tract Infection ◽  
Disease State ◽  
Management Guideline ◽  
State Management ◽  
Disease State Management

Effect of Visit Frequency of Pharmacist-Led Diabetes Medication Management Program

2020 ◽  
pp. 089719002094868
Author(s):  
Amy Frederick ◽  
Joyce Juan ◽  
Delaney Ivy ◽  
Yolanda Munoz Maldonado
Keyword(s):  
Blood Pressure ◽  
Hemoglobin A1c ◽  
Medication Management ◽  
Retrospective Chart Review ◽  
Management Program ◽  
P Value ◽  
State Management ◽  
Disease State Management ◽  
Visit Frequency ◽  
Patients With Diabetes

Background: Pharmacists have a positive effect on clinical outcomes in chronic disease state management, however, few studies have evaluated the effect that frequency of visits may have on diabetes biomarkers such as hemoglobin A1c and blood pressure readings. Methods: Under the medication management program (MMP), patients with diabetes were seen monthly by pharmacists until early 2015, when time between visits was increased to every 3 months. A retrospective chart review was conducted to evaluate the primary outcome of the percent change in hemoglobin A1c and blood pressure after the change in visit frequency. Results: In the 303 patients enrolled, no statistical difference existed between the pre and post average A1c (p-value = 0.10). The intermediate average A1c was statistically lower from the preintervention mean A1c (p-value = 0.001) but not from the postintervention mean A1c (p-value = 0.30). No statistical differences were seen between systolic blood pressure and diastolic blood pressure. Conclusion: Patients who have been seen by a clinical pharmacist more frequently (every month or every other month) for several years may be able to maintain their reduction in A1c with less-frequent visits (every 3 to 6 months).

scholarly journals DA5 Disease State Management Tracker: Implementing, Tracking, And Evaluating Clinical Pathways And Outcomes

1998 ◽  
Vol 1 (1) ◽  
pp. 88-89
Author(s):  
AJ Ambegaonkar ◽  
D Day ◽  
J Main ◽  
T Lubowski ◽  
C Yamaga ◽  
...  
Keyword(s):  
Clinical Pathways ◽  
Disease State ◽  
State Management ◽  
Disease State Management
Sign in / Sign up

Export Citation Format

Share Document